2026 NPPES data Ambulatory Care Pharmacist NPI 1033727334 PHARMD
Verify on CMS →

NATALIE GREENLEE, PHARMD

Ambulatory Care Pharmacist in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
433
Medicare Part D claims · 50 beneficiaries · Ambulatory Care Pharmacist avg: 492
Generic prescribing
74%
generic claims · 26% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

NATALIE GREENLEE, PHARMD filed 433 Medicare Part D claims in 2023 as a Ambulatory Care Pharmacist in BROOKLYN, New York, prescribing 74% generic.

433
Part D claims, 2023
74%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NATALIE GREENLEE, PHARMD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

433 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about NATALIE GREENLEE, PHARMD?

Quality data not reported

NPI registry status

Active

Issued 07/22/2020

NPI 1033727334

Primary specialty

Ambulatory Care Pharmacist

Niche

3,473 US NPIs in this specialty

Medicare Part D claims

433 12% vs specialty avg

2023 prescription claims

Specialty avg: 492

Specialty distribution in New York

How Ambulatory Care Pharmacist compares to other specialties among New York providers

New York providers

Ambulatory Care Pharmacist share within New York

1. Ambulatory Care Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ambulatory Care Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Ambulatory Care Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ambulatory Care Pharmacist ABMS/AOA estimate

Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ambulatory Care Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NATALIE GREENLEE, PHARMD is a Ambulatory Care Pharmacist provider practicing in BROOKLYN, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PHARMD. NPI: 1033727334. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NATALIE GREENLEE, PHARMD appears in the CMS NPPES registry as a Ambulatory Care Pharmacist provider holding PHARMD credentials at 760 BROADWAY, BROOKLYN, NY, 11206, with a listed phone of (718) 963-8000. NPI 1033727334 was issued on 07/22/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GREENLEE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 433 prescription claims written by this provider, covering 50 Medicare beneficiaries and totaling roughly $131K in drug spend, split 26% brand-name and 74% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ambulatory Care Pharmacist is a narrow specialty nationwide, with 3,473 enrolled providers across 52 states and an average of 492 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

760 BROADWAY
BROOKLYN, NY 11206

Provider Details

NPI 1033727334
Specialty Ambulatory Care Pharmacist
Credentials PHARMD
Gender Female
NPI Issued 07/22/2020

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to NATALIE GREENLEE, PHARMD. To verify NATALIE GREENLEE, PHARMD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NATALIE GREENLEE, PHARMD — brand share 26.0%
Specialty average (est.)

26% brand-name claims vs 74% generic, on 433 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

433
Total Claims
$131K
Total Drug Cost
50
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
602
Total Day Supply
15,712
Brand vs Generic
26% brand / 74% generic
Brand Drug Cost
$126K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
68.1 years
Avg HCC Risk Score
2.02
Gender Split
64% female / 36% male
Age Distribution
<65: 14, 65-74: 24, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Warfarin Sodium
231
Trulicity
Dulaglutide
23
Novolog Flexpen
Insulin Aspart
19
Amlodipine Besylate
13
Ozempic
Semaglutide
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ambulatory Care Pharmacist Overview

How NATALIE GREENLEE, PHARMD fits within the Ambulatory Care Pharmacist landscape nationally.

3,473
Ambulatory Care Pharmacist Providers in US
52
States with Ambulatory Care Pharmacist
492
Avg Claims per Provider

NATALIE GREENLEE, PHARMD's 433 claims are below the specialty average of 492.

Nearby Ambulatory Care Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GREENLEE.

Compare Ambulatory Care Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is NATALIE GREENLEE, PHARMD's specialty?
NATALIE GREENLEE, PHARMD specializes in Ambulatory Care Pharmacist and practices in BROOKLYN, New York. Credentials: PHARMD.
How much does NATALIE GREENLEE, PHARMD prescribe under Medicare Part D?
In 2023, NATALIE GREENLEE, PHARMD wrote 433 Medicare Part D claims totaling $131K in drug costs for 50 beneficiaries.
Where is NATALIE GREENLEE, PHARMD located?
NATALIE GREENLEE, PHARMD is located at 760 BROADWAY, BROOKLYN, NY, 11206. Phone: (718) 963-8000.
What is NATALIE GREENLEE, PHARMD's NPI number?
NATALIE GREENLEE, PHARMD's National Provider Identifier (NPI) is 1033727334, issued on 07/22/2020.
Does NATALIE GREENLEE, PHARMD prescribe more brand-name or generic drugs?
NATALIE GREENLEE, PHARMD's prescribing is 26% brand-name and 74% generic drugs by claim count, with $126K in brand drug costs.
How many Ambulatory Care Pharmacist providers are there in the US?
There are 3,473 Ambulatory Care Pharmacist providers across 52 states in the US. The average Ambulatory Care Pharmacist provider writes 492 Medicare Part D claims per year.
What drugs does NATALIE GREENLEE, PHARMD prescribe most often?
Based on 2023 Medicare Part D data, NATALIE GREENLEE, PHARMD's most frequently prescribed drugs include Warfarin Sodium, Trulicity, Novolog Flexpen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NATALIE GREENLEE, PHARMD accept Medicare?
NATALIE GREENLEE, PHARMD appears in CMS Medicare data with 433 Part D claims and 50 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NATALIE GREENLEE, PHARMD's credentials?
NATALIE GREENLEE, PHARMD's NPI is 1033727334 with credentials PHARMD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology